News life sciences News Publications
Sunday August 21st, 2022
Sorry, this entry is only available in Polish.
Sorry, this entry is only available in Polish.
We are pleased to inform that veterinary clinic “Wróblewscy” located in Dąbrowa Górnicza has joined AniCura, a family of leading…
On April 10, 2024, the European Parliament adopted an update of four of the seven so-called “breakfast directives”[1] – directives…
On January 1, 2024, an amendment to the Public Health Act entered into force, revolutionizing the energy drinks market in…
SK&S’ transaction team has advised AniCura AB in the acquisition process of veterinary clinic “Centrum Zdrowia Małych Zwierząt” in Poznań,…
In July last year, we reported that due to ongoing discussions, the possibility of limiting the sale of energy drinks…
SK&S’ transaction team advised Velocity Clinical Research Inc.—the leading multi-specialty clinical sites business, in the acquisition of KO-MED Clinical Centers—one…
General information CBD (cannabidiol) has been steadily gaining popularity for some years now, and the global CBD market is expected…
We are pleased to inform that veterinary clinic “Molicki” located in Dąbrowa Górnicza has joined AniCura, a family of leading…
At the end of June, the European Commission (EC) published an updated “Blue Guide”, which, first published in 2000, has…
As we informed in a last SK&S report, electronic cigarettes, particularly disposable ones, have been the subject of public debate…
During a January meeting of the Parliamentary Committee on Economy and Development,[1] the President of the Office of Competition and…
Electronic cigarettes, especially disposable ones, have recently been the subject of public debate, primarily due to the announcement of restrictions…
On the website of the Government Legislation Centre on January 2 this year, a draft act amending the act on…
An updated guideline for borderline products has been published on the European Commission website. For many product categories (e.g. medical…
SK&S’ transaction team advised Velocity Clinical Research Inc.—the leading multi-specialty clinical sites business, in the acquisition of its first site…